Global AT1 Receptor Antagonists Market to Witness Steady Growth through 2025

Posted on 2018-11-06 by Mark Hub in Industrial, Pharmaceuticals // 0 Comments

Albany, US, 2018-Nov-06 — /EPR Network/ —This research report titled “Global AT1 Receptor Antagonists Market Insights, Forecast to 2025” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the AT1 Receptor Antagonists market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about the actual scenario prevailing in the AT1 Receptor Antagonists market.

Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1928551

AT1receptor antagonists are a group of pharmaceuticals that modulate thereninangiotensin system. Their main uses are in the treatment ofhypertension(high blood pressure),diabetic nephropathy(kidney damage due todiabetes) andcongestive heart failure. Theyblockthe activation ofAT1receptors, preventing thebindingofangiotensin II.
In 2017, the global AT1 Receptor Antagonists market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the AT1 Receptor Antagonists market based on company, product type, application and key regions.

This report studies the global market size of AT1 Receptor Antagonists in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of AT1 Receptor Antagonists in these regions.
This research report categorizes the global AT1 Receptor Antagonists market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

The various contributors involved in the value chain of AT1 Receptor Antagonists include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the AT1 Receptor Antagonists include
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly and Company
Sanofi SA
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Size Split by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market Size Split by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global AT1 Receptor Antagonists market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of AT1 Receptor Antagonists market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global AT1 Receptor Antagonists manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the AT1 Receptor Antagonists with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of AT1 Receptor Antagonists submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of AT1 Receptor Antagonists are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of AT1 Receptor Antagonists market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-at1-receptor-antagonists-market-insightsforecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 AT1 Receptor Antagonists Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global AT1 Receptor Antagonists Market Size
2.1.1 Global AT1 Receptor Antagonists Revenue 2016-2025
2.1.2 Global AT1 Receptor Antagonists Sales 2016-2025
2.2 AT1 Receptor Antagonists Growth Rate by Regions
2.2.1 Global AT1 Receptor Antagonists Sales by Regions
2.2.2 Global AT1 Receptor Antagonists Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers
3.1.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.2 AT1 Receptor Antagonists Revenue by Manufacturers
3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2016-2018)
3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2016-2018)
3.3 AT1 Receptor Antagonists Price by Manufacturers
3.4 AT1 Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers AT1 Receptor Antagonists Product Category
3.4.3 Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global AT1 Receptor Antagonists Sales by Type
4.2 Global AT1 Receptor Antagonists Revenue by Type
4.3 AT1 Receptor Antagonists Price by Type

Continue…@@$

Enquire about this Report – https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1928551

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharma market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick